
Sign up to save your podcasts
Or
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
4.3
1818 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
130 Listeners
321 Listeners
161 Listeners
478 Listeners
687 Listeners
37 Listeners
275 Listeners
3,320 Listeners
8 Listeners
17 Listeners
14 Listeners
11 Listeners
5 Listeners
6 Listeners
8 Listeners
22 Listeners
91 Listeners
134 Listeners
1,084 Listeners
5 Listeners
29 Listeners
14 Listeners
176 Listeners
512 Listeners
5 Listeners
318 Listeners
413 Listeners
105 Listeners
17 Listeners
365 Listeners
2 Listeners
165 Listeners